CORSODYL MOUTHWASH

País: Israel

Idioma: inglés

Fuente: Ministry of Health

Cómpralo ahora

Ingredientes activos:

CHLORHEXIDINE DIGLUCONATE

Disponible desde:

GSK CONSUMER HEALTHCARE, ISRAEL LTD

Código ATC:

A01AB03

formulario farmacéutico:

SOLUTION

Composición:

CHLORHEXIDINE DIGLUCONATE 0.2 %W/V

Vía de administración:

LOCAL ORAL

tipo de receta:

Not required

Fabricado por:

PURNA PHARMACEUTICALS, BELGIUM

Grupo terapéutico:

CHLORHEXIDINE

Área terapéutica:

CHLORHEXIDINE

indicaciones terapéuticas:

Antibacterial solution for the disinfection of the mouth.1. As an aid to maintaining oral hygiene.2. As an aid in the treatment and prevention of gingivitis.3. Inhibition of formation of dental plaque.4. For use in aphtous ulceration and oral candidal infections (eg denture stomatitis and thrush).5. For use in a post- periodontal surgery or treatment regimen to promote gingival healing.

Fecha de autorización:

2019-08-31

Información para el usuario

                                2017 (
) – 1986
: 0.2% W/V
CHLORHEXIDINE DIGLUCONATE 0.2% W/V
6.
.
.
,
.
12
.
12
,
.
.
,
.
1.
?
•
•
(
)
•
•
,
•
,
,
,
: А
2.
,
.
• 12
,
.
•
.
.
-
,
.
•
.
“
”.
•
.
“
”
.
•
,
.
•
.
“
”.
•
,
.
“
”.
,
,
,
,
.
,
.
.
3.
?
,
.
,
.
.
.
.
5
,
,
.
.
:
.
10
.
,
.
:
. (
)
:
2
.
:
15 .
:
.
,
.
!
.
.
4.
,
.
.
,
.
,
,
,
.
Э
,
.
,
,
.
,
: . Э
.
.
.
,
,
–
,
(
.
“
”).
,
.
.
,
,
,
.
.
–
.
,
.
,
“
”,
(www.health.gov.il)
,
,
:
https://sideeffects.health.gov.il/
,
,
,
,
,
.
5.
?
! Э
,
,
,
/
,
.
.
(exp. date),
.
.
+25º
. 6
.
6.
, -
Purified water, Sorbitol, Glycerol, Macrogolglycerol hydroxystearate
and Optamint 291616
flavour. -
,
,
.
,
300
.
: GSK
.,
/ 3256,
.
:
GmbH & Co. KG,
,
.
2014.
2017,
: 029-96-21599
GSK.
©2019
GSK
.
_Cor MW PT v7a_
_ _
                                
                                Leer el documento completo
                                
                            

Ficha técnica

                                SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Corsodyl 0.2% Mouthwash
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Chlorhexidine Digluconate 0.2% w/v
(equivalent to Chlorhexidine Digluconate Solution 1.028% w/w)
Also contains macrogolglycerol hydroxystearate. For a full list of
excipients,
see section 6.1.
3.
PHARMACEUTICAL FORM
Oromucosal solution
A clear to slightly opalescent, transparent solution with an odour of
peppermint.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Antibacterial solution for the disinfection of the mouth.
1. As an aid to maintaining oral hygiene.
2. As an aid in the treatment and prevention of gingivitis.
3. Inhibition of formation of dental plaque.
4. For use in aphtous ulceration and oral candidal infections (eg
denture
stomatitis and thrush).
5. For use in a post- periodontal surgery or treatment regimen to
promote
gingival healing.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults:
Thoroughly rinse the mouth for about one minute with 10 ml twice
daily. Spit
out after use. In the dental surgery, the patient should be instructed
to rinse the
mouth for one minute prior to treatment.
For the treatment of gingivitis, a course of about one month is
advisable
although some variation in response is to be expected. In the case of
aphthous
ulceration and oral candidal infections treatment should be continued
for 48
hours after clinical resolution. For the treatment of dental
stomatitis, the
dentures should be cleansed and soaked in Corsodyl 0.2% Mouthwash for
fifteen minutes twice daily.
Do not exceed the stated dose.
Children and the Elderly:
The normal adult dose is appropriate for elderly patients and children
of 12 years
and over unless otherwise recommended by the dentist or the physician.
Children under 12 years of age should not use the product unless
recommended
by a healthcare professional.
Route of administration
Oromucosal use. [This product is not intended to be swallowed].
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the exc
                                
                                Leer el documento completo
                                
                            

Documentos en otros idiomas

Información para el usuario Información para el usuario árabe 24-11-2023
Información para el usuario Información para el usuario hebreo 26-11-2017

Buscar alertas relacionadas con este producto